Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1475Neoplasms 996Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 682Stomach Neoplasms 646Lung Neoplasms 583Prostatic Neoplasms 543Pancreatic Neoplasms 457Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 289Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 276Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 240Multiple Myeloma 232Brain Neoplasms 203Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 191Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 140

Interventions

Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Efficacy and Safety × Clear all
NCT04284215 2020-02-25

Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC

Guizhou Medical University

Phase NA Unknown
68 enrolled

Efficacy and Safety

NCT03255343 2017-08-21

ImDendrim

French Association for the Advancement Medical Research

Phase NA Unknown
10 enrolled

Efficacy and Safety

Data powered by HemOnc (CC BY 4.0) Colophon âš¡